InvestorsHub Logo

DewDiligence

11/02/17 10:57 AM

#203 RE: DewDiligence #196

ORPN 9/30/17 cash=$4.1M (down from $5.2M at 6/30/17):

https://finance.yahoo.com/news/bioblast-pharma-reports-third-quarter-113000168.html